1. FDA clears narrow use of Lynparza in early prostate cancer — AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral --FDA approves Pfizer’s RSV vaccine for older adults -- See more on our front page news http://bit.ly/w28kSd See more on our front page news
    Dismiss Notice

Create Thread

A moderated forum to discuss general whistleblower/fraud issues with attorneys specializing in this area.

Verification:

(CustomImgCaptcha By Surrey Forum)

Tags:

Multiple tags may be separated by commas.

By submitting this post, you agree to be bound to the terms and conditions of our site.

Post a Poll

Possible Responses:
Maximum Selectable Responses:

This is the maximum number of responses a voter may select when voting.

Options: